https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-reports-third-quarter-2026-financial-results-and-hh1o4r7doxpt.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-reports-third-quarter-2026-financial-results-and-hh1o4r7doxpt.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/QTI/qt-imaging-secures-medicare-outpatient-reimbursement-for-q-tscan-zm9r26xcv196.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/QTI/qt-imaging-secures-medicare-outpatient-reimbursement-for-q-tscan-zm9r26xcv196.html?utm_source=stocktitan-bluesky&utm_medium=social
Resignation of Garry Nicholson and Gabriela Gruia, M.D. On October 13, 2026, each of Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board of Directors of TScan Therapeutics, Inc. and each committee thereof, in each case effective as of October 13, 2026 . Neither Mr. Nicholson...
Resignation of Garry Nicholson and Gabriela Gruia, M.D. On October 13, 2026, each of Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board of Directors of TScan Therapeutics, Inc. and each committee thereof, in each case effective as of October 13, 2026 . Neither Mr. Nicholson...
On September 8, 2026, the Compensation Committee of the Board of Directors of TScan Therapeutics, Inc. approved a retention program designed to retain the employees required to support the Company, including a key employee retention program that provides for cash awards and the potential ...
On September 8, 2026, the Compensation Committee of the Board of Directors of TScan Therapeutics, Inc. approved a retention program designed to retain the employees required to support the Company, including a key employee retention program that provides for cash awards and the potential ...
https://fundspec.ai/s/TCRX/analysts
Draw trendlines and run technical studies on pro grade charts.
https://fundspec.ai/s/TCRX/analysts
Draw trendlines and run technical studies on pro grade charts.
Follow Us for More!
Disclaimer: This is NOT a financial advice
Follow Us for More!
Disclaimer: This is NOT a financial advice
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-strategic-reorganization-to-focus-on-5dn3kehaphte.html
https://www.stocktitan.net/news/TCRX/t-scan-therapeutics-announces-strategic-reorganization-to-focus-on-5dn3kehaphte.html
Phase 3 ALLOHA-2 Enrollment Paused; Heme Malignancies Program Paused Due to Capital Constraints
TScan announced a strategic reorganization prioritizing its in vivo solid tumor program, pausing further enrollment in the pivotal Phas…
https://biostock.app/symbols/TCRX
Phase 3 ALLOHA-2 Enrollment Paused; Heme Malignancies Program Paused Due to Capital Constraints
TScan announced a strategic reorganization prioritizing its in vivo solid tumor program, pausing further enrollment in the pivotal Phas…
https://biostock.app/symbols/TCRX